Construction, Characterization, and Application of a Nonpathogenic Virus-like Model for SARS-CoV-2 Nucleocapsid Protein by Phage Display

• Published in: Toxins Vol. 14; no. 10; p. 683
• Main Authors: Wu, Yuting, Liu, Bing, Liu, Zhiwei, Zhang, Pengjie, Mu, Xihui, Tong, Zhaoyang
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01-10-2022; MDPI
• Subjects: Antibodies; Binding sites; Biosafety; Coronaviruses; COVID-19; COVID-19 vaccines; Dengue fever; Discriminant analysis; Disease transmission; Display devices; Enzyme-linked immunosorbent assay; Enzymes; Glycoproteins; Identification and classification; Immunology; M13 phage; Medical research; Methods; nucleocapsid protein; Nucleocapsids; p3 protein; Pandemics; Pathogenicity; Pathogens; Phage display; Phages; Polypeptides; Proteins; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Spectrum analysis; Viral diseases; Viruses; Western immunoblotting; China
• ISSN: 2072-6651; 2072-6651
• DOI: 10.3390/toxins14100683

With the outbreak and spread of COVID-19, a deep investigation of SARS-CoV-2 is urgent. Direct usage of this virus for scientific research could provide reliable results and authenticity. However, it is strictly constrained and unrealistic due to its high pathogenicity and infectiousness. Considering its biosafety, different systems and technologies have been employed in immunology and biomedical studies. In this study, phage display technology was used to construct a nonpathogenic model for COVID-19 research. The nucleocapsid protein of SARS-CoV-2 was fused with the M13 phage capsid p3 protein and expressed on the M13 phages. After validation of its successful expression, its potential as the standard for qPCR quantification and affinity with antibodies were confirmed, which may show the possibility of using this nonpathogenic bacteriophage to replace the pathogenic virus in scientific research concerning SARS-CoV-2. In addition, the model was used to develop a system for the classification and identification of different samples using ATR–FTIR, which may provide an idea for the development and evaluation of virus monitoring equipment in the future.